Newbridge Financial Services Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-193
| Closed | -$2.75K | – | 1296 |
|
|
2023
Q4 | $2.75K | Sell |
193
-141
| -42% | -$2.01K | ﹤0.01% | 940 |
|
|
2023
Q3 | $5.17K | Buy |
334
+2
| +0.6% | +$31 | ﹤0.01% | 943 |
|
|
2023
Q2 | $5.21K | Hold |
332
| – | – | ﹤0.01% | 1001 |
|
|
2023
Q1 | $5.47K | Hold |
332
| – | – | ﹤0.01% | 1045 |
|
|
2022
Q4 | $5.18K | Buy |
332
+3
| +0.9% | +$47 | ﹤0.01% | 1059 |
|
|
2022
Q3 | $4K | Buy |
329
+2
| +0.6% | +$24 | ﹤0.01% | 1102 |
|
|
2022
Q2 | $5K | Hold |
327
| – | – | ﹤0.01% | 1027 |
|
|
2022
Q1 | $5K | Hold |
327
| – | – | ﹤0.01% | 1115 |
|
|
2021
Q4 | $4K | Buy |
327
+196
| +150% | +$2.4K | ﹤0.01% | 1130 |
|
|
2021
Q3 | $2K | Buy |
131
+3
| +2% | +$46 | ﹤0.01% | 1202 |
|
|
2021
Q2 | $2K | Hold |
128
| – | – | ﹤0.01% | 1305 |
|
|
2021
Q1 | $2K | Buy |
+128
| New | +$2K | ﹤0.01% | 1202 |
|